共 43 条
- [1] Kratochwil C(2019)(68)Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer J Nucl Med 60 801-805
- [2] Flechsig P(2021)Liver metastases from medullary thyroid carcinoma detected on (68)Ga-FAPI-04 PET/CT Endocrine 74 727-728
- [3] Lindner T(2016)Recent updates on the management of medullary thyroid carcinoma Endocrinol Metab (Seoul) 31 392-399
- [4] Abderrahim L(2020)EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma Eur J Nucl Med Mol Imaging 47 61-77
- [5] Altmann A(2006)Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases Cancer 107 2134-2142
- [6] Mier W(1993)In vivo somatostatin receptor imaging in medullary thyroid carcinoma J Clin Endocrinol Metab 76 1413-1417
- [7] Kuyumcu S(2022)New PET radiotracers for the imaging of neuroendocrine neoplasms Curr Treat Options Oncol 23 703-720
- [8] Isik EG(2021)A theranostic approach of [(68)Ga]Ga-DOTA.SA.FAPi PET/CT-guided [(177)Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy Eur J Nucl Med Mol Imaging 48 942-4
- [9] Sanli Y(2023)PET imaging of fibroblast activation protein in various types of cancer using (68)Ga-FAP-2286: comparison with (18)F-FDG and (68)Ga-FAPI-46 in a single-center, prospective study J Nucl Med 64 386-394
- [10] Kim BH(undefined)undefined undefined undefined undefined-undefined